Back to Authors

Wang, T.

A5042068951 | I266595603

Mayo Clinic

Genmab (United States)

Citations 3

Comparison of clinical outcomes in patients with relapsed/refractory large B‐cell lymphoma treated with epcoritamab versus chemoimmunotherapy

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 433-434

10.1002/hon.3164_319

COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB‐BASED REGIMENS, AND TAFASITAMAB‐BASED REGIMENS

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 790-792

10.1002/hon.3165_639

P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1042-1043

10.1097/01.hs9.0000847488.86807.da